0 Yorumlar
0 hisse senetleri
792 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Digital Therapeutics Market Analysis: Growth Drivers, Market Trends and Forecast"Global Executive Summary Digital Therapeutics Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The report has provided crucial information about the...0 Yorumlar 0 hisse senetleri 644 Views 0 önizleme
-
Digital Therapeutics market Future Outlook and Growth Potential Report"Digital Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Digital Therapeutics Market Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period...0 Yorumlar 0 hisse senetleri 390 Views 0 önizleme
-
Digital Therapeutics Market Research Report: Industry Trends, Demand and Future Outlook"Key Drivers Impacting Executive Summary Digital Therapeutics Market Size and Share Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The Digital Therapeutics Market report contains...0 Yorumlar 0 hisse senetleri 497 Views 0 önizleme
-
Lung Transplant Therapeutics Market Growth and Future TrendsLung Transplant Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Transplant Therapeutics Market CAGR Value The global lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the...0 Yorumlar 0 hisse senetleri 344 Views 0 önizleme
-
Microbiome-Based Therapeutics Market Forecast: Industry Size, Share, and Future Trends"Global Executive Summary Microbiome-Based Therapeutics Market: Size, Share, and Forecast The global Microbiome-Based Therapeutics market size was valued at USD 3.17 billion in 2024 and is expected to reach USD 18.29 billion by 2032, at a CAGR of 24.50% during the forecast period This Microbiome-Based Therapeutics Market research report contains specific...0 Yorumlar 0 hisse senetleri 638 Views 0 önizleme
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 Yorumlar 0 hisse senetleri 623 Views 0 önizleme
-
Rare Pediatric Epilepsy Therapeutics market Competitive Analysis Report for Leading Companies"Rare Pediatric Epilepsy Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Rare Pediatric Epilepsy Therapeutics Market The global rare pediatric epilepsy therapeutics market size was valued at USD 198.00 Million in 2025 and is expected to reach USD 466.90 Million by 2033, at a CAGR of 11.32% during the forecast period The data,...0 Yorumlar 0 hisse senetleri 169 Views 0 önizleme
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Dynamics: Key Drivers and Restraints 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The key...0 Yorumlar 0 hisse senetleri 448 Views 0 önizleme
-
(R)-Homopipecolic Acid Market Projected at USD 52.6M by 2034: Chiral Non-Proteinogenic Amino Acid Unlocks Next-Gen CNS Therapeutics at 7.2% CAGRGlobal (R)-Homopipecolic acid market was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a remarkable CAGR of 7.2% during the forecast period. (R)-Homopipecolic acid is a non-proteinogenic amino acid and a chiral building block characterized by its six-membered nitrogen-containing ring structure. As an...0 Yorumlar 0 hisse senetleri 247 Views 0 önizleme
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 Yorumlar 0 hisse senetleri 235 Views 0 önizleme
-
(S)-N-Boc-3-Bromophenylalanine Market Surges to USD 52.7M by 2034 Driven by Peptide Therapeutics BoomGlobal (S)-N-Boc-3-Bromophenylalanine (CAS 82278-73-7) market was valued at USD 28.4 million in 2025 and is projected to reach USD 52.7 million by 2034, exhibiting a remarkable CAGR of 7.3% during the forecast period. (S)-N-Boc-3-Bromophenylalanine (CAS 82278-73-7), a Boc-protected unnatural amino acid derivative featuring a bromine substituent at the meta position of the phenylalanine...0 Yorumlar 0 hisse senetleri 238 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction Adult malignant gliomas are among the most aggressive and lethal cancers of the central nervous system. Originating in the glial cells of the brain, these tumors are characterized by rapid progression, high recurrence rates, and limited long-term survival outcomes. The most common and severe type, glioblastoma multiforme (GBM), remains extremely challenging to treat, despite...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Growth Drivers: Share, Value, Size, and Insights"Executive Summary Adult Malignant Glioma Therapeutics Market Research: Share and Size Intelligence Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report makes available the...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Industry Statistics: Growth, Share, Value, Insights, and Trends"Market Trends Shaping Executive Summary Adult Malignant Glioma Therapeutics Market Size and Share Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report performs geographical...0 Yorumlar 0 hisse senetleri 948 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Scope: Growth, Share, Value, Size, and Trends"Executive Summary Adult Malignant Glioma Therapeutics Market Market Size and Share Across Top Segments CAGR Value Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market Market report has...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market: Comprehensive Analysis and Future OutlookIntroduction Adult malignant glioma represents one of the most aggressive and lethal forms of primary brain tumors, posing a significant clinical and economic burden worldwide. Characterized by rapid progression, invasive growth, and limited responsiveness to conventional therapies, malignant gliomas—particularly glioblastoma—continue to challenge oncologists and neuroscientists...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue Analysis Industry Outlook, ForecastAnalysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Yorumlar 0 hisse senetleri 495 Views 0 önizleme
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue, Key Factors, Major Companies, Forecast Analysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Yorumlar 0 hisse senetleri 515 Views 0 önizleme
Arama Sonuçları
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek